Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-041551
Filing Date
2013-07-26
Accepted
2013-07-26 16:59:14
Documents
1
Period of Report
2013-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd386250.html 4  
1 FORM 4 rrd386250.xml 4 6713
  Complete submission text file 0001181431-13-041551.txt   8377
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD., SUITE 110 POINT RICHMOND CA 94804
Business Address
Kennedy Joseph T (Reporting) CIK: 0001408920 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 13990109